Short- and long-term outlook after emergency admission for acute heart failure
Short and Long Term Prognosis of Patients Admitted to the Emergency Department With Acute Heart Failure
This project will try to see how people admitted to the emergency department with acute heart failure do at 30 days and one year, comparing those with reduced versus preserved ejection fraction.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University of Monastir Academic / other |
| Locations | 1 site (Monastir, Monastir Governorate) |
| Trial ID | NCT03806972 on ClinicalTrials.gov |
What this trial studies
This is an observational cohort of adults admitted to the Emergency Department at the University of Monastir with a primary discharge diagnosis of acute heart failure. Patients will be classified as heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF) and baseline clinical data will be recorded. The main outcomes are mortality and rehospitalization at 30 days and one year, determined through clinic follow-up and medical record review. Pregnant or breastfeeding patients, those with altered consciousness or needing immediate mechanical/hemodynamic/ventilatory support, and individuals unable to comply with follow-up are excluded and no interventional treatments are assigned.
Who should consider this trial
Good fit: Adults admitted to the Emergency Department at the University of Monastir with a primary discharge diagnosis of acute heart failure who can consent and comply with follow-up.
Not a fit: Patients who are pregnant or breastfeeding, those with altered consciousness or requiring immediate mechanical or ventilatory support, or those unable to comply with follow-up are excluded and unlikely to benefit from this observational work.
Why it matters
Potential benefit: If successful, the results could help clinicians predict which emergency-admitted heart failure patients are at higher short- and long-term risk and improve follow-up and care planning.
How similar studies have performed: Many prior observational studies have compared outcomes between HFrEF and HFpEF, so this project builds on an established evidence base rather than introducing a novel treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients admitted to the ED of Monastir with a principal discharge diagnosis code for HF. Exclusion Criteria: * Pregnant or breast feeding women. Alteration of consciousness GCS \< 15 Critically ill patients needing immediate mechanical hemodynamic of ventilatory support. Inability to follow instructions or comply with follow-up procedures.
Where this trial is running
Monastir, Monastir Governorate
- Emergency Departement — Monastir, Monastir Governorate, Tunisia (Recruiting)
Study contacts
- Principal investigator: Nouira Semir, Professor — university Hospital of Monastir
- Study coordinator: Nouira Semir, Professor
- Email: semir.nouira@rns.tn
- Phone: 73106000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.